PierianDx Customers Cite ‘Creative Partnership’ on Clinical Genomics as Key Selling Point
NEW YORK (GenomeWeb) – Last week, PierianDx announced six new customers for its Clinical Genomicist Workspace (CGW), including Cedars-Sinai Medical Center, Dartmouth-Hitchcock Medical Center, Florida Hospital, Georgia Esoteric & Molecular Laboratory at Augusta University, NorthShore University HealthSystem, and the University of Arkansas for Medical Sciences.
That brings the customer count to more than 40 and is key to realizing what PierianDx considers to be equally important to CGW, its one-stop shop for clinical genomics: a network of leading pathologists, generating a proprietary knowledgebase of clinically actionable information.
“We saw the benefits of this network on day one,” Niki Sidiropoulos, medical director at the
University of Vermont Medical Center’s Genomic Medicine laboratory, said in an interview. Vermont has implemented NGS in “care pathways” for oncology, pharmacogenomics, and inherited diseases and is collecting data for research it hopes will make the case nationally for the clinical utility of NGS, leading to reimbursement.
Some customers, like UVMMC, have mostly focused on using the CGW, while others, like the Moffitt Cancer Center in Tampa, Florida, have used almost every available service offered, a PierianDx spokesperson said. Both were early customers and PierianDx has since expanded to offer a variety of professional services beyond the software, including implementation services, custom assay validation, and even turnkey assays that customers
can brand as their own. But representatives from both praised the firm’s willingness to engage with their unique demands as they ventured into NGS-powered clinical genomics.